Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Venous Thromboembolism 3Neoplasms 3Venous Thrombosis 2Thromboembolism 2Pulmonary Embolism 2Ovarian Neoplasms 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Thrombosis 1Sarcoma 1Postoperative Complications 1Lung Neoplasms 1Fallopian Tube Neoplasms 1Esophageal Neoplasms 1Endometrial Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Dalteparin 9apixaban 7Tinzaparin 5Enoxaparin 5Rivaroxaban 3Dabigatran 3Warfarin 2Heparin, Low-Molecular-Weight 2Fondaparinux 2perflutren 1enoxaparin sodium 1edoxaban 1bemiparin 1Sulfur Hexafluoride 1Rosuvastatin Calcium 1Phenprocoumon 1Nephrectomy 1Nadroparin 1Hospitals 1Heparin 1Fluorodeoxyglucose F18 1Educational Status 1Deoxyribonucleases 1Aspirin 1Acenocoumarol 14-((1,4,8,11-tetraazacyclotetradec-1-yl)methyl)benzoic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Pulmonary Embolism × Fondaparinux × Clear all
NCT02744092 2023-10-03

CANVAS

Alliance Foundation Trials, LLC.

Phase NA Completed
811 enrolled 19 charts
Classical hematology

Neoplasms, Pulmonary Embolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

NCT01727427 2019-08-08

Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients

G. d'Annunzio University

Completed
695 enrolled

Neoplasms, Pulmonary Embolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡